PATENT CLAIM ANALYSIS

Application Number: 15742093
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Aspects of the invention relate to methods for treating ALS comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding superoxide dismutase 1 (SOD1).

Claim (Index 14):
The composition of  claim 13 , further comprising a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.13889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13636755', '13636728', '14729006', '15099481', '14728653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8466592120889948
- 35 USC 102 Novelty (BERT): 0.6066547643004685
- Combined Prediction Score: 0.8226587673101421
- Mean Citation Score: 498.6139359999999
- Max Citation Score: 534.2475
- Similarity Product: 329.09422916248434

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test